Related Experiment Videos
AIDS-associated non-Hodgkin's lymphoma
1San Francisco General Hospital, California.
Current Opinion in Oncology
|October 1, 1989
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Changes in the influence of lymphoma- and HIV-specific factors on outcomes in AIDS-related non-Hodgkin lymphoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2015
Spectral band passes for a high precision satellite sounder.
Applied optics·2010
Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor. National Institute of Allergy and Infectious Diseases.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1998
Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·1998
Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.
Current opinion in oncology·2026
Deep learning assisting the surgical management of gynecologic cancers.
Current opinion in oncology·2026
Pain management in pancreatic cancer: time to change our strategy!
Current opinion in oncology·2026
Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.
Current opinion in oncology·2026
Lifestyle medicine for cancer survivorship.
Current opinion in oncology·2026
Dabrafenib-Induced Cutaneous Eruptions in a Patient With Langerhans Cell Histiocytosis.
Case reports in dermatological medicine·2026
Type 1 diabetes mellitus induced by sintilimab: a case report and related case literature analysis.
Frontiers in endocrinology·2026
Lipocalin-2 Emerges as a Core Pathogenic Mediator and Biomarker in Autosomal Dominant Tubulointerstitial Kidney Disease-UMOD via Transcriptomic Profiling.
Kidney diseases (Basel, Switzerland)·2026
Targeting TKT-associated immunometabolic remodeling attenuates experimental lupus nephritis and NET-related inflammation.
Frontiers in cell and developmental biology·2026